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Abstract- Ultrasound is one of the preferred modalities for evaluation of the parathyroid glands. This study 
was undertaken to determine the accuracy of high resolution ultrasound for secondary hyperparathyroidism in 
patients with chronic renal failure. From March 2008 to March 2009, ninety-one hemodialysis patients were 
examined by high resolution ultrasound (14 MHz) of the parathyroid glands in comparison to parathyroid 
hormone level. 43.9% of patients showed enlarged parathyroid glands with an average of 8.7 mm. The mean 
parathyroid hormone level of patients with enlarged parathyroid glands on sonography was 503  ±  450 
pg/ml. We observed a significant correlation between parathyroid hormone level and enlarged parathyroid 
glands (P<0.0001). Sensitivity and specificity of sonography for detection of secondary hyperparathyroidism 
were 62.5% and 85.7% respectively. In conclusion, our study showed that high resolution sonography is a 
useful noninvasive method for the evaluation of secondary hyperparathyroidism in patients on hemodialysis 
and that sonographically enlarged glands may be a measure of severity of secondary hyperparathyroidism. 
© 2011 Tehran University of Medical Sciences. All rights reserved. 
Acta Medica Iranica 2011; 49(8): 527-530.          . 
 





Secondary hyperparathyroidism (sHPT) is one of the 
main features of bone disease seen in chronic dialysis 
patients. This abnormality is characterized by the high-
turnover bone disease caused by excess parathyroid 
hormone (PTH) secreted from hyperplastic parathyroid 
glands (1). Imaging of the parathyroid can be performed 
with nuclear medicine, ultrasound, CT, and MRI. 
Indications for parathyroid imaging studies have 
recently changed. The availability of experienced 
endocrine surgeons, as well as the development of 
accurate laboratory tests, fine-needle aspiration (FNA) 
biopsy, and high-resolution ultrasound, has dramatically 
influenced the evaluation of parathyroid disease (2). The 
accuracy of imaging techniques is directly related to the 
examiner experience, equipment available, and 
parathyroid pathology involved (3). Severity of sHPT 
has been evaluated mainly by the level of PTH. It is now 
well established that serum PTH is the gold standard for 
diagnosis of secondary hyperparathyroidism. However, 
parathyroid size can be an alternative marker (4). The 
objective of the present approach was to assess the 
sensitivity, specificity, and positive and negative 
predictive values of high resolution sonography for the 
diagnosis of sHPT. 
 
Patients and Methods 
 
High-resolution sonography of the neck was performed 
in 91 patients undergoing renal dialysis to determine the 
usefulness of sonography in the evaluation of sHPT. 
This study was conducted within the Department of 
Radiology at Imam Hospital, Ardebil University of 
Medical Sciences (northwest of Iran) between March 
2008 and March 2009. All ultrasound examinations 
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were performed by an expert sonologist with 12 years of 
experience using a high resolution real time linear 
ultrasound unit (model ultrasonix SP) with 10-14 MHz 
multi frequency probe. Sonographic studies were 
performed without knowledge of the patients' symptoms 
or the results of PTH assays. Patients were positioned 
with their necks hyperextended so that the entire neck 
could be evaluated from the mandible to the thoracic 
inlet. The neck in the area of the thyroid was examined 
first. If no enlarged parathyroid gland (EPTGs) was 
detected, further evaluation of the neck above and below 
the thyroid was performed. Parathyroid glands were 
evaluated for size. PTH levels were measured in all 
patients by electrochemiluminescence immunoassay 
(ECLIA), E170/Elecyc2010 model (Roche). 
Comparison of the sonographic findings and PTH was 
performed and data were analyzed. The sensitivity, 
specificity, and positive and negative predictive values 
were determined for sonographic assessment, for 




A total of ninety-one patients who underwent renal 
dialysis were analyzed. 30/91 (33%) were women and 
61/91 (67%) patients were men. Average age of patients 
was 53.6 ± 16.1 (age range 15-83) years. The sonograms 
in 40/91 (43.9%) patients showed EPTGs, with an 
average size of 8.7 mm. Ultrasound image representative 
of EPTG is shown in Figure 1. The mean PTH level of 
patients was 283 ± 366 pg/ml (rage: 2 to 1755pg/ml). 
The PTH level in patients with  and  without  EPTGs  on  
 
Figure 1. Enlarged parathyroid gland in secondary 
parathyroidism caused by chronic renal failure 
 
 
sonography is presented in Table 1. There was a 
statistically significant difference in PTH levels between 
two groups using t-test (P=0.0001). 
Comparison of the sonographic findings and 
laboratory test of PTH level are demonstrated in Table 
2. 
The sensitivity of sonography for diagnosis of 
EPTGs was 62.5% (CI95%: 52.6%-72.4%), the specificity 
was 85.7%, the positive predictive value (PPV) 87.5%, 
the negative predictive value (NPV)58.8%, the positive 
likelihood ratio (LR+) was 4.37, and the negative 
likelihood ratio (LR-) was 0.43. 
Sonographic findings were inconsistence from 
laboratory test of PTH level in 26 of 91 patients. A 
correct sonographic diagnosis was obtained in 65 of 91 






Table 1. Summary of PTH level of patients with chronic renal failure (n=91) 
Results on sonography No (%) Mean (pg/ml) SD (pg/ml) 
Present EPTGs  40 (43.9) 503 450.03 





Table 2. Comparison of results as assessed by sonography and PTH level 







Positive (present of EPTGs) 35 5 40 
Negative (absent of EPTGs) 21 30 51 
Total 56 35 91 
H. Anari, et al. 




High-resolution real time sonography performed by 
using a 7.5 or10 MHz transducer can provide better 
images of small parts in superficial organs (5). The 
progression of chronic renal failure (CRF) is associated 
with presence of bone disease and hyperplasia of 
parathyroid glands (6). A large population of patients 
maintained on long-term dialysis exists who develop 
severe sHPT (7). Hyperparathyroidism is a relatively 
common disease, especially among patients suffering 
from chronic renal failure (CRF) (8). In CRF 
insufficiency secondary hyperparathyroidism occurs as a 
result of parathyroid cell hyperplasia with enlargement 
of the parathyroid glands (9). Prolonged renal failure 
decreases ionized-calcium levels and increases retention 
of serum phosphate (10, 11). This directly stimulates the 
parathyroid glands to secrete more parathyroid 
hormones in the body (12). sHPT means that external 
factores stimulate the parathyroid glands to increase the 
production of PTH (13). The most common condition 
causing sHPT is CRF, an insidious disease that develops 
early in the course of the chronic kidney disease and 
increases in severity as the glomerular filtration rate 
deteriorates. Basically, imaged-based localizing tests 
depend on gland size; therefore, because patients with 
sHPT tend to have large glands, the specificity and 
positive value of sonography is much greater for sHPT 
than for primary hyperplasia (14). Sonography have 
been useful for the screening and follow up of patients 
with sHPT and may contribute to indication for surgery 
by estimating the size of enlarged glands. It has a 
reported sensitivity of 45-70% (13). It has been well 
documented in the literature that high resolution gray 
scale sonography is highly accurate in localizing EPTGs 
(15). Some more invasive methods have a good 
sensitivity and should be used in the event of 
reoperations such as intravenous PTH sampling (16, 17). 
Based on our results sensitivity, specificity and PPV of 
high resolution sonography for diagnosis of EPTGs was 
62.5%, 85.7%, and 87.5%, respectively. Similar study 
by Aysum et al., documented that in sHPT sonography 
had sensitivity of 60%, a specificity of 91%, PPV of 
92% (18). Another study by Nidal et al., indicated that 
the sensitivity of ultrasound is 39%, PPV 64%. Their 
findings was comparable with the results of our study 
(39%, 62.5%), respectively. It seems to be because of 
glandular size, weight, experience of physician and 
sensitivity of the probe (19). Arnold et al., in their work 
demonstrated that sensitivity and specificity using high 
resolution real time sonography (7.5 MHz) for 
evaluation of parathyroid glands is 57%, 96%, 
respectively (20). Comparison of our approach to others 
indicated that sensitivity of high resolution ultrasound 
(14 MHz) is higher than the 7.5 MHz. In conclusion, our 
results show that high resolution ultrasound is an 
effective noninvasive method in diagnosis of sHPT in 
patients with CRF and that sonographically enlarged 
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